SCHEMBL624923

SCHEMBL624923

Cc1cnc(C2(C(N)=O)CC2)cc1[Sn](C)(C)C

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ NNMT P40261 1/20 0.32
▸ FLT4 P35916 3/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15057742 0.71 USP30 (0.32) —
SCHEMBL625875 0.67 RAB9A (0.36) NNMT
SCHEMBL30907651 0.67 OPRL1 (0.36) FLT4
SCHEMBL31533689 0.67 LMNA (0.43) —
SCHEMBL9942800 0.66 ABL1 (0.56) —
SCHEMBL31473604 0.65 NNMT (0.33) NNMT
SCHEMBL27172580 0.65 NNMT (0.40) NNMTFLT4
SCHEMBL28841914 0.65 CA2 (0.32) —
SCHEMBL30161959 0.65 CA2 (0.32) —
SCHEMBL622310 0.65 ABL1 (0.51) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2603216-A1 HETEROARYLS AND USES THEREOF Millennium Pharmaceuticals, Inc. (US) 2013-06-19 — — EP disclosed
WO-2012021615-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-02-16 — — WO disclosed
Send feedback